McLean Hospital
Belmont, Massachusetts, 02478, United States
NCT Number: NCT02695953
Posttraumatic stress disorder (PTSD) is a significant personal and societal burden. The purpose of this study is to examine genetic, epigenetic, behavioral, and brain activity changes related to PTSD dysfunction and recovery before and after treatment with Cognitive Processing Therapy.
Interested in participating?
Request Info18 year–55 year
All sexes
Observational
Belmont, Massachusetts, 02478, United States
Using functional magnetic resonance imaging approaches, the present research aims to examine the relationship between traumatic experience and the neural mechanisms of various PTSD symptoms, and determine how this relationship changes during PTSD extinction. Also, this proposal aims to better understand how the genetic/epigenetic profile of several genes predicts, and perhaps changes, in response to recovery from PTSD along with its neural correlates. This understanding will help identify individuals who will respond most optimally to a specific empirically based PTSD treatment, Cognitive Processing Therapy, while further connecting genetic biomarkers of risk with neural intermediate phenotypes underlying PTSD symptomatology.This study is observational as the investigator does not assign specific interventions to the participants of the study.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Within 30 days before and again within 30 days after Cognitive Processing Therapy Treatment.
Milissa Kaufman
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05624931
Behavior, Behavioral Symptoms
Boston, Massachusetts, United States
View Trial DetailsNCT07693686
Mental Disorders, Posttraumatic Stress Disorder
San Diego, California, United States
View Trial DetailsNCT06788678
Mental Disorders, Posttraumatic Stress Disorder
Temple, Texas, United States
View Trial DetailsNCT06449326
Mental Disorders, Posttraumatic Stress Disorder
Albuquerque, New Mexico, United States
View Trial Details